Show simple item record

dc.contributor.authorTahghighi, A
dc.contributor.authorEmami, S
dc.contributor.authorRazmi, S
dc.contributor.authorMarznaki, FR
dc.contributor.authorArdestani, SK
dc.contributor.authorDastmalchi, S
dc.contributor.authorKobarfard, F
dc.contributor.authorShafiee, A
dc.contributor.authorForoumadi, A
dc.date.accessioned2018-08-26T07:57:49Z
dc.date.available2018-08-26T07:57:49Z
dc.date.issued2013
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/49130
dc.description.abstractA novel series of 5-(5-nitrofuran-2-yl)-and 5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazole-2-amines bearing acyclic amine at C-2 position of thiadiazole ring were synthesized and evaluated in vitro against promastigote and amastigote forms of Leishmania major. The structure-activity of series was investigated by studying 40 compounds. The most active derivatives were hydroxypropylamino-and methoxypropylamino-analogs of 5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazole (compounds 29 and 32, respectively) with highest selectivity index (SI > 12).
dc.language.isoEnglish
dc.relation.ispartofJOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
dc.subjectAntileishmanial activity
dc.subject5-nitrofuran
dc.subject5-nitrothiophene
dc.subject1,3,4-thiadiazole
dc.titleNew 5-(nitroheteroaryl)-1,3,4-thiadiazols containing acyclic amines at C-2: synthesis and SAR study for their antileishmanial activity
dc.typeArticle
dc.citation.volume28
dc.citation.issue4
dc.citation.spage843
dc.citation.epage852
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.3109/14756366.2012.689297


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record